IP Library Granted Patent US 7,655,781
Granted Patent B2
US 7,655,781 · App. 11/429,553 · Granted Feb 2, 2010

Variants of human glycoprotein hormone alpha chain: compositions and uses thereof

Assignees: Compugen Ltd.; Protalix Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,655,781
App. No.
11/429,553
Granted
Feb 2, 2010
Kind
B2
Abstract

The present invention provides human glycoprotein hormone (hGPH) α-chain splice variants, including isolated nucleic acids encoding these variants and the encoded amino acid sequences, as well as antibodies, antisense oligonucleotides, expression vectors and host cells comprising these sequences. The present invention further discloses the use of these sequences in the diagnosis, prevention and treatment of symptoms, diseases and disorders related to glycoprotein hormones.

Claims (12)

1. An isolated polynucleotide comprising the nucleic acid sequence of SEQ ID NO: 1.

2. An isolated polynucleotide encoding a polypeptide having at least one hGPH activity wherein said polynucleotide comprises nucleotides 190-282 of SEQ ID NO: 1 in a polynucleotide of at least 695 bases.

3. The polynucleotide according to claim 1 encoding a polypeptide having at least one hGPH α-chain activity.

4. An isolated polynucleotide comprising a nucleic acid sequence encoding a polypeptide having the sequence set forth in SEQ ID NO: 2.

5. An isolated polynucleotide comprising a nucleic acid sequence complementary to the nucleic acid sequence according to claim 4 or claim 2 .

6. An expression vector comprising the polynucleotide sequence of claim 1 or claim 2 .

7. A host cell comprising the vector according to claim 6 .

8. A process for producing a polypeptide which comprises:

culturing the host cell according to claim 7 , wherein the host cell is a transformed carrot cell, under conditions suitable to produce the polypeptide encoded by the polynucleotide; and

recovering said polypeptide.

9. The process of claim 8 , wherein the transformed carrot cell is a cell from carrot callus.

10. The process of claim 8 , wherein the conditions comprise culturing the transformed carrot cell in suspension.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Sep 6, 2024
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS COLLATERAL AGENT
To: PROTALIX LTD.
Reel/Frame 068856/0589 →
SECURITY INTEREST Recorded Dec 12, 2016
From: PROTALIX LTD.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB
Reel/Frame 040708/0661 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2007
From: SHEMESH, RONEN; BERNSTEIN, JEANNE; DAHARY, DVIR; SHALEV, GIL; BAUM, GIDEON; SHAALTIEL, YOSEPH
To: COMPUGEN LTD.; PROTALIX LTD.
Reel/Frame 018772/0715 →
Continuity (4)
Continuation PCTIL200400101700 · Nov 7, 2004
Continuation 1098437900 · Nov 8, 2004
Provisional Application 6051737800 · Nov 6, 2003
Related Publication 20070298463A1 · Dec 27, 2007